Zhang Z, et al. Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. PLoS ONE. 2012;7: e49265.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Weston S, et al. A membrane topology model for human interferon inducible transmembrane protein 1. PLoS ONE. 2014;9: e104341.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Li C, et al. Antiviral role of IFITM proteins in classical swine fever virus Infection. Viruses. 2019;11:126–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewin AR, et al. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem. 1991;199:417–23.

Article  CAS  PubMed  Google Scholar 

Siegrist F, et al. The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res. 2011;31:183–97.

Article  CAS  PubMed  Google Scholar 

John SP, et al. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol. 2013;87:7837–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan YK, et al. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection. PLoS ONE. 2012;7: e34508.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Feeley EM, et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011;7: e1002337.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu J, et al. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011;85:2126–37.

Article  CAS  PubMed  Google Scholar 

Bozzo CP, et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021;12:4584.

Article  ADS  Google Scholar 

Gomez-Herranz M, et al. IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity. J Biol Chem. 2023;299: 102741.

Article  CAS  PubMed  Google Scholar 

Liu X, et al. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-beta signaling pathway. Cell Death Dis. 2019;10:517.

Article  PubMed  PubMed Central  Google Scholar 

Xu L, et al. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis. Cancer Lett. 2017;393:76–85.

Article  CAS  PubMed  Google Scholar 

Hu J, et al. Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer. Oncol Rep. 2014;32:2648–56.

Article  CAS  PubMed  Google Scholar 

Yu F, et al. IFITM1 promotes the metastasis of human colorectal cancer via CAV-1. Cancer Lett. 2015;368:135–43.

Article  CAS  PubMed  Google Scholar 

Yang J, et al. Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer. Cancer Sci. 2018;109:3115–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tirosh B, et al. “1-8 interferon inducible gene family”: putative colon carcinoma-associated antigens. Br J Cancer. 2007;97:1655–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniel-Carmi V, et al. The human 1–8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene. Int J Cancer. 2009;125:2810–9.

Article  CAS  PubMed  Google Scholar 

Andreu P, et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006;66:1949–55.

Article  CAS  PubMed  Google Scholar 

Yang N, et al. Predicative value of IFITM2 in renal clear cell carcinoma: IFITM2 is associated with lymphatic metastasis and poor clinical outcome. Biochem Biophys Res Commun. 2021;534:157–64.

Article  CAS  PubMed  Google Scholar 

Cai Y, et al. Interferon-induced transmembrane protein 3 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors. Front Immunol. 2021;12: 704965.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Y, et al. Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation. Biochem Biophys Res Commun. 2018;495:733–9.

Article  CAS  PubMed  Google Scholar 

Koh YW, et al. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma. Pathol Res Pract. 2019;215: 152444.

Article  CAS  PubMed  Google Scholar 

Sakamoto S, et al. Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer. Int J Mol Sci. 2020;21(14):4934.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lui AJ, et al. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett. 2017;399:29–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, et al. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Oncol Rep. 2013;30:171–8.

Article  CAS  PubMed  Google Scholar 

Hou Y, et al. Interferon-induced transmembrane protein 3 expression upregulation is involved in progression of hepatocellular carcinoma. Biomed Res Int. 2021;2021:5612138.

Article  PubMed  PubMed Central  Google Scholar 

Seyfried NT, et al. Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett. 2008;263:243–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao B, et al. The role of IFITM3 in the growth and migration of human glioma cells. BMC Neurol. 2013;13:210.

Article  PubMed  PubMed Central  Google Scholar 

Mizoshiri N, et al. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma. Cell Oncol (Dordr). 2019;42:861–71.

Article  CAS  PubMed  Google Scholar 

Liu Y, et al. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Ther. 2020;27:38–44.

Article  CAS  PubMed  Google Scholar 

Liang Y, et al. Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming. Mol Cancer. 2022;21:182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akyerli CB, et al. Expression of IFITM1 in chronic myeloid leukemia patients. Leuk Res. 2005;29:283–6.

Article  CAS  PubMed  Google Scholar 

Carmelle R, et al. Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biol Ther. 2006;5:1383–9.

Article  Google Scholar 

Wu L, et al. Identification of IFN-induced transmembrane protein 1 with prognostic value in pancreatic cancer using network module-based analysis. Front Oncol. 2021;11: 626883.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei Z, et al. Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells. Biosci Biotechnol Biochem. 2020;84:1603–13.

Article  Google Scholar 

Yang G, et al. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene. 2007;26:594–603.

Article  CAS  PubMed  Googl